Grupo Fleury
Octavio de Lazari Junior, appointed to the position of alternate member of Mr. Samuel Monteiro on the Board of Directors, started his career at Banco Bradesco SA in 1978. He was elected Deputy Executive Director of Bradesco SA in 2012, Managing Executive Director in 2015 and Vice Chief Executive Officer in 2017. He is a specialist in Financial Strategies and Marketing at Fundação Instituto de Administração – FEA/USP, Financial Management at Fundação Getúlio Vargas – FGV and Strategies in Finance at Fundação Dom Cabral, having completed the AMP – Advanced Management Program – given by IESE Business School – University of Navarra, São Paulo and is currently Chief Executive Officer of Bradesco SA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.